The Medicaid and Health Choice Preferred Drug List (PDL) Review Panel was established by DHHS to conduct open meetings to discuss recommended policies and procedures related to the PDL and to address the public comments that were received during the PDL comment period. The administration and review of the North Carolina Medicaid and Health Choice Preferred Drug List follow the Preferred Drug List Review Panel Guidelines and Procedures.
Approved recommendations from the Medicaid PDL Review Panel:
Panel Member |
Position |
Organization |
Dr. Cedric M. Bright |
Physician |
Old North State Medical Society |
Dr. Paul Bush |
Pharmacist |
Hospital-Based Pharmacy |
Dr. Tom Wroth |
Physician |
Community Care of NC |
Dr. Stefanie Ferreri |
Pharmacist |
NC Association of Pharmacists |
Dr. Theresa M. Flynn |
Physician |
NC Pediatric Society |
Dr. Burt Johnson |
Physician |
NC Psychiatric Association |
Dr. Byron J. Hoffman |
Physician |
NC Chapter of the American College of Physicians |
Dr. Robert L. (Chuck) Rich |
Physician |
NC Academy of Family Physicians |
Dr. William Sheridan |
Physician |
Research-Based Pharmaceutical Company |
Dr. Beat Steiner |
Physician |
NC Physician Advisory Group Pharmacy and Therapeutics Committee |
Dr. Lisa Weeks |
Pharmacist |
NC Division of Medical Assistance |